logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
Breast Cancer 封面图

Breast Cancer

IF2.9
论文数2261
被引数3595
期刊论文 2261
发表时间
delete
Prognostic performance of the Japanese Breast Cancer Society pathological response classification after neoadjuvant chemotherapy新辅助化疗后日本乳腺癌协会病理反应分级的预后性能
deleteBreast Cancer
IF2.9
delete2026-10-27
delete0
PREAI
deleteYumiko Ushiyama; Yuko Ueki; Yoshiya Horimoto; Mariko Yoshino; Yumiko Ishizuka; Ryoko Semba; Hideo Shimizu; Kanako Ogura; Takuo Hayashi; Takashi Ishikawa; Junichiro Watanabe; Goro Kutomi
delete分享
delete收藏
Molecular mechanisms and targeted therapeutic strategies of TIGAR in regulating energy metabolism to promote tumor proliferation in breast cancerTIGAR在调节能量代谢以促进乳腺癌肿瘤增殖方面的分子机制和靶向治疗策略
deleteBreast Cancer
IF2.9
delete2026-10-25
delete0
PREAI
deleteMengyi Zhai; Peiying Wang; Yetao Ou
delete分享
delete收藏
A phase II study combining radiotherapy and atezolizumab/nab-paclitaxel for inoperable or recurrent programmed death-ligand 1-positive triple-negative breast cancer: IMRad-Br study protocol and safety run-in不可手术或复发的程序性死亡配体1阳性三阴性乳腺癌中，联合放射治疗和阿替利珠单抗/白蛋白结合型紫杉醇的II期研究：IMRad-Br研究方案和安全性导入
deleteBreast Cancer
IF2.9
delete2026-10-21
delete0
deleteOAAI
deleteHiroshi Ishiguro; Nobuhiro Hoshi; Shin-ei Noda; Emi Tokuda; Asami Nukui; Yuya Yoshimoto; Fumiaki Takahashi; Shigehira Saji; Shingo Kato; Tohru Ohtake; Akihiko Osaki; Yoshiyuki Suzuki
delete分享
delete收藏
Time toxicity in breast cancer care: a nationwide cross-sectional survey of multidimensional time burden in Japan乳腺癌治疗中的时间毒性：日本全国范围内对多维时间负担的横断面调查
deleteBreast Cancer
IF2.9
delete2026-10-15
delete0
PREAI
deleteHitomi Suzuki; Misato Tsukuda; Nobuko Ueda; Tomoko Yodogawa; Yukinori Arata; Tsukushi Kaji; Shotaro Oshikawa
delete分享
delete收藏
Limited clinical value of routine PET/CT in early-stage breast cancer: a multicenter retrospective study早期乳腺癌常规PET/CT检查的临床价值有限：一项多中心回顾性研究
deleteBreast Cancer
IF2.9
delete2026-10-13
delete0
PREAI
deleteKassem Salam; Hasan Numan; Ali Elhadi Zreik; Mohamad Baqer Skaini; Ali Ghais; Chadi Abou Khater; Dany Nassar; Hady Ghanem; Fadi El Karak; Malek Safa; Nagi Saghir; Hiba Moukadem; Arafat Tfayli
delete分享
delete收藏
Comparison of four breast lymphoedema patient reported outcome measures in women following breast conserving surgery and radiotherapy: examination of frequencies of symptoms and measurement properties四种乳腺癌淋巴水肿患者报告结局测量工具在行保乳手术和放疗的女性中的比较：症状频率和测量属性的考察
deleteBreast Cancer
IF2.9
delete2026-10-08
delete0
deleteOAAI
deleteNicola Fearn; Sharon Kilbreath; Elizabeth Dylke; Wei Wang; Catalina Llanos; Verity Ahern; Elisabeth Elder; Farid Meybodi; Nicholas Olsen; Kirsty Stuart
delete分享
delete收藏
Target trial emulation of first-line ribociclib versus palbociclib in hormone receptor-positive, HER2-negative metastatic breast cancer: a comparative effectiveness study激素受体阳性、HER2阴性转移性乳腺癌中，比较作为一线治疗的ribociclib与palbociclib的实效性研究：一项目标试验模拟
deleteBreast Cancer
IF2.9
delete2026-10-06
delete0
PREAI
deleteXiaoyi Zhang; Po-Huang Chen; Wei-Cheng Chang; Hong-Jie Jhou; Hsin-Yu Chen; Li-Ting Kao; Tina Yi-Jin Hsieh; Ming-Shen Dai; Na Xiao; Cho-Hao Lee
delete分享
delete收藏
Preoperative CA15-3 as a predictor of axillary lymph node metastasis and prognosis in women with breast cancer: a GRADE-assessed systematic review and meta-analysis术前CA15-3作为预测乳腺癌女性腋窝淋巴结转移和预后的指标：一项经过GRADE评估的系统评价和荟萃分析
deleteBreast Cancer
IF2.9
delete2026-10-05
delete0
PREAI
deleteMansour Bahardoust; Anita Rezaei; Anahita Hosseinali; Golnaz Ranjbarpazuki; Sajad Salehi; Meisam Haghmoradi; Shoboo Rahmati; Nahid Nafissi
delete分享
delete收藏
Effects of exercise and educational programs on long-term quality of life, anxiety, and depression in breast cancer survivors: an exploratory secondary analysis of the Setouchi breast project-10 randomized controlled trial运动和教育项目对乳腺癌幸存者长期生活质量、焦虑和抑郁的影响：Setouchi乳腺癌项目-10随机对照试验的探索性二次分析
deleteBreast Cancer
IF2.9
delete2026-10-03
delete0
PREAI
deleteAzusa Jo; Takayuki Iwamoto; Kengo Kawada; Youko Suzuki; Kyoko Hara; Seiji Yoshitomi; Daisuke Takabatake; Shinichiro Kubo; Yutaka Ogasawara; Shozo Ohsumi; Masahiko Ikeda; Hiroyoshi Doihara; Yuri Mizota; Seiichiro Yamamoto; Naruto Taira
delete分享
delete收藏
Long-term outcomes of invasive lobular carcinoma compared with invasive ductal carcinoma in HR-positive/HER2-negative breast cancer: a focus on luminal subtypes人激素受体阳性/HER2阴性乳腺癌中浸润性小叶癌与浸润性导管癌的长期预后比较：重点关注管腔亚型
deleteBreast Cancer
IF2.9
delete2026-10-03
delete0
PREAI
deleteSayoko Kakimoto; Hiroyuki Yamamoto; Junki Koike; Koichiro Tsugawa
delete分享
delete收藏
Mindful eating as a supportive intervention for breast cancer survivors: a pilot randomized controlled trial正念饮食作为乳腺癌幸存者支持性干预措施：一项初步随机对照试验
deleteBreast Cancer
IF2.9
delete2026-09-27
delete0
deleteOAAI
deleteDilşat Baş; Gizem Ağır; Özlem Sönmez; Ece Öneş
delete分享
delete收藏
Clinical impact of ENIGMA-based variant reclassification on genotype–phenotype analyses in BRCA1- and BRCA2-associated hereditary breast and ovarian cancerENIGMA基线变异重分类对BRCA1和BRCA2相关遗传性乳腺癌和卵巢癌基因型-表型分析的临床影响
deleteBreast Cancer
IF2.9
delete2026-09-25
delete0
PREAI
deleteSaid Furkan Yildirim; Pervin Demir; Hakan Kosku; Bulent Yalcin; Ahmet Cevdet Ceylan
delete分享
delete收藏
Triggering receptors expressed on myeloid cells (TREM-1) and TREM-2 as predictors of pathological complete response to neoadjuvant therapy in triple-negative breast cancer髓系细胞表达触发受体（TREM-1）和TREM-2作为三阴性乳腺癌新辅助治疗病理完全缓解的预测因子
deleteBreast Cancer
IF2.9
delete2026-09-21
delete0
deleteOAAI
deleteNazan Demir; İvo Gökmen; Duygu Bayır Garbioğlu; Ebru Taştekin; Emre Işık; Erkan Özcan; Bülent Erdoğan; Sernaz Topaloğlu; Bahadır Köylü; Cevat İlteriş Kıkılı; Fatih Kemik; İrfan Çiçin; Fatih Selçukbiricik; Muhammet Bekir Hacıoğlu
delete分享
delete收藏
Five-year outcomes of partial breast proton beam therapy without lumpectomy for early-stage breast cancer: an interventional prospective study早期乳腺癌部分乳腺质子束放疗不联合保乳手术的五年疗效：一项干预性前瞻性研究
deleteBreast Cancer
IF2.9
delete2026-09-19
delete0
PREAI
deleteEtsuyo Ogo; Takeshi Arimura; Takashi Ogino; Uhi Toh; Kenta Murotani; Ichiro Isomoto; Makoto Kubo; Reiki Nishimura; Yusaku Miyata; Gen Suzuki; Yoshio Hishikawa; Shoshu Mitsuyama; Ryoichi Nagata
delete分享
delete收藏
Pathologic complete response and survival according to germline BRCA1/2 status in triple-negative breast cancer三阴性乳腺癌中胚系BRCA1/2状态与病理完全缓解及预后的关系
deleteBreast Cancer
IF2.9
delete2026-09-10
delete0
deleteOAAI
deletePaulina Gebhart; Florian Heinzl; Chiara Kahl; Alev Bari; Georg Langs; Daniela Muhr; Christian F. Singer; Yen Y. Tan
delete分享
delete收藏
Correction: Initial activities and prospects of MIRAY1: a youth-driven, society-endorsed initiative to cultivate future breast cancer physicians更正：MIRAY1的初始活动与展望：一个由青年主导、社会认可的培养未来乳腺癌医师的倡议
deleteBreast Cancer
IF2.9
delete2026-09-06
delete0
PREAI
deleteHiroko Masuda; Takaaki Konishi; Mai Onishi; Aki Ito; Kazunoshin Tachibana; Akari Murakami; Atsushi Fushimi; Ryota Otsubo; Haruru Kotani; Yuri Kimura; Yuka Inoue; Yukinori Ozaki; Kaori Tane; Tsutomu Iwasa; Yuko Takahashi; Yuko Kanemoto; Yurika Iida; Chiaki Kudo; Sayuka Nakayama; Takahiro Suzuki; Midori Morita; Riko Sato; Masafumi Iida; Akihiko Ozaki; Mai Kitazawa; Mio Adachi; Masafumi Inokuchi; Chikako Yamauchi; Takanori Ishida; Norikazu Masuda; Masakazu Toi
delete分享
delete收藏
Exercise prehabilitation in breast cancer surgery: are we measuring the right outcomes?乳腺癌手术中的运动预康复：我们是否测量了正确的结局指标？
deleteBreast Cancer
IF2.9
delete2026-09-03
delete0
PREAI
deleteKadri Altundag
delete分享
delete收藏
Association between preoperative body composition and health-related quality of life in breast cancer patients: a prospective Eastern European study术前身体成分与乳腺癌患者健康相关生活质量的关系：一项前瞻性东欧研究
deleteBreast Cancer
IF2.9
delete2026-09-03
delete0
deleteOAAI
deleteKatarzyna Mielniczek; Radosław Mlak; Aleksandra Kowalska; Katarzyna Jóźwik; Karol Rawicz-Pruszyński; Zuzanna Pelc
delete分享
delete收藏
Correction: Prognostic model based on six PD‑1 expression and immune infiltration‑associated genes predicts survival in breast cancer校正：基于六个PD-1表达和免疫浸润相关基因的预后模型预测乳腺癌患者生存
deleteBreast Cancer
IF2.9
delete2026-09-03
delete0
PREAI
deleteShen Junjun; Zhuang Jing; Pu Jie; Chu Jian; Pan Yuefen; Han Shuwen
delete分享
delete收藏
Real-world outcomes of datopotamab deruxtecan after trastuzumab deruxtecan in hormone receptor–positive, HER2-negative metastatic breast cancer曲拉妥单抗德鲁克替康后，在激素受体阳性、HER2阴性转移性乳腺癌中的真实世界结局
deleteBreast Cancer
IF2.9
delete2026-09-02
delete0
deleteOAAI
deleteYosuke Aoyama; Yukinori Ozaki; Masahiro Kuno; Rika Kizawa; Jun Masuda; Meiko Nishimura; Mami Kurata; Lina Inagaki; Mari Hosonaga; Ippei Fukada; Tetsuyo Maeda; Kazuyo Yoshida; Nami Yamashita; Takayuki Kobayashi; Toshimi Takano; Takayuki Ueno
delete分享
delete收藏